Huang, Shile <br/><br/>
A new clue to explain resistance to mTOR inhibitors.  [electronic resource] 

 -  Cell cycle (Georgetown, Tex.)  Mar 2012 
 - 844 p.  digital 
<br/><br/> Publication Type: News 
<br/><br/><label>ISSN: </label>1551-4005 
<br/><br/><label>Standard No.: </label>10.4161/cc.11.5.19598  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adaptor Proteins, Signal Transducing--metabolism<br/>Antineoplastic Agents--therapeutic use<br/>Cell Cycle Proteins<br/>Drug Resistance, Neoplasm<br/>Everolimus<br/>Humans<br/>Neoplasms--drug therapy<br/>Phosphoproteins--metabolism<br/>Phosphorylation<br/>Protein Kinase Inhibitors--therapeutic use<br/>Proto-Oncogene Proteins c-akt--metabolism<br/>Ribosomal Protein S6 Kinases--metabolism<br/>Sirolimus--analogs & derivatives<br/>TOR Serine-Threonine Kinases--antagonists & inhibitors<br/>Tacrolimus Binding Protein 1A--metabolism